A Randomized Controlled Trial to Evaluate Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes: REmission Studies Evaluating Type 2 DM - Intermittent Insulin Therapy (RESET-IT)
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Insulin glargine (Primary) ; Insulin lispro (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms RESET-IT
- 16 Aug 2018 Biomarkers information updated
- 01 Apr 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 21 Jan 2013 New trial record